Olfa Derbel
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
-
- Sarcoma Diagnosis and Treatment
- Advanced Breast Cancer Therapies
Papers in
- Oncology 10
- PARP inhibition in cancer therapy 5
- Cancer Immunotherapy and Biomarkers 2
-
- Ovarian cancer diagnosis and treatment 5
- Co-authors
- Jean‐Yves Blay (12 shared papers)Philippe Alexandre Cassier (6 shared papers)Isabelle Laure Ray-Coquard (11 shared papers)Anne‐Valérie Decouvelaere (4 shared papers)Pierre Méeus (5 shared papers)Christelle de la Fouchardière (6 shared papers)Dominique Ranchère‐Vince (3 shared papers)Gualter Vaz (3 shared papers)
- Journals
- Annals of Oncology (5 papers)BMC Cancer (4 papers)Nature Communications (2 papers)The Breast (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- FranceSpainSwitzerland
In The Last Decade
Olfa Derbel
32 papers receiving 852 citations
Olfa Derbel's Hit Papers
Peers
Comparison fields: 5 of 41
- Cancer Research 178
- Pulmonary and Respiratory Medicine 298
- Rheumatology 92
- Oncology 148
- Endocrinology, Diabetes and Metabolism 85
Countries citing papers authored by Olfa Derbel
This map shows the geographic impact of Olfa Derbel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olfa Derbel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olfa Derbel more than expected).
Fields of papers citing papers by Olfa Derbel
This network shows the impact of papers produced by Olfa Derbel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olfa Derbel. The network helps show where Olfa Derbel may publish in the future.
Co-authors
The 25 scholars most cited alongside Olfa Derbel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2022 | 255 |
| 2 | 2011 | 73 | |
| 3 | 2017 | 73 | |
| 4 | 2013 | 66 | |
| 5 | 2013 | 59 | |
| 6 | 2017 | 51 | |
| 7 | 2015 | 42 | |
| 8 | 2012 | 31 | |
| 9 | 2019 | 25 | |
| 10 | 2013 | 23 | |
| 11 | 2024 | 23 | |
| 12 | 2012 | 22 | |
| 13 | 2019 | 18 | |
| 14 | 2019 | 13 | |
| 15 | 2024 | 13 | |
| 16 | 2012 | 11 | |
| 17 | 2015 | 10 | |
| 18 | 2013 | 8 | |
| 19 | 2011 | 7 | |
| 20 | 2013 | 6 |
About Olfa Derbel
Olfa Derbel is a scholar working on Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine, Cancer Research and Rheumatology, having authored 34 papers that have together received 869 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (5 papers), Ovarian cancer diagnosis and treatment (5 papers), PARP inhibition in cancer therapy (5 papers), BRCA gene mutations in cancer (4 papers), Bone Tumor Diagnosis and Treatments (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (178 citations), Pulmonary and Respiratory Medicine (298 citations), Rheumatology (92 citations), Oncology (148 citations) and Endocrinology, Diabetes and Metabolism (85 citations). Olfa Derbel has collaborated with scholars based in France, Spain and Switzerland. Frequent co-authors include Jean‐Yves Blay, Philippe Alexandre Cassier, Isabelle Laure Ray-Coquard, Anne‐Valérie Decouvelaere, Pierre Méeus, Christelle de la Fouchardière, Dominique Ranchère‐Vince, Gualter Vaz, Alice Bonneville-Levard and Olivier Collard. Their work appears in journals such as Annals of Oncology, BMC Cancer, Nature Communications, The Breast and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.